No Detail Found!

Secretagogin (SCGN) Plasma Levels and Their Association with Cognitive and Social Behavior in Children with Autism Spectrum Disorder (ASD).

Author(s)
Abdulrahman Mohammed Alhowikan Department of Physiology, Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia
Laila AlAyadhi Department of Physiology, Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia
Dost Muhammad Halepoto Department of Physiology, Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia
Abstract
Objective: To investigate the secretagogin (SCGN) plasma levels in children with autism spectrum disorder (ASD) compared to age and gender-matched healthy control, and its association with cognitive and social behaviors by using childhood autism rating scale (CARS) and social responsiveness scale (SRS). Study Design: Case-control study. Place and Duration of Study: Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Department of Physiology, Faculty of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia, from October 2015 to May 2016. Methodology: SCGN levels were determined in the plasma of thirty-seven (37) autistic children using enzyme-linked immunosorbent assay (ELISA), categorized as mild-moderate and severe as indicated by their CARS scores and compared with thirty (30) age and gender-matched control samples. Correlation between SCGN levels and different cognitive and social behavior scales (CARS and SRS) was determined by Spearman's correlation coefficient (r). Results: The results indicated that autistic children (n=37) had significantly (p= 0.005) lower plasma level of SCGN {45.7 (26.2) ng/ml [median (IQR)]} than those of healthy controls {n=30, 70.8 (48.6) ng/ml [median (IQR)]}. Children with severe (n=28, 76%) as well as mild to moderate autism (n=09, 24%) also exhibited significantly lower SCGN levels {47.5 (27) ng/ml [median (IQR)], p =0.014} and {45.7 (16.6) ng/ml [median (IQR)], p = 0.02)}, respectively than healthy controls {n=30, 70.8 (48.6) ng/ml [median (IQR)]}. However, there was no significant difference between the SCGN levels of children with mild to moderate and severe autism (p = 0.66). Spearman's correlation coefficient (r) was used to determine the relationships between SCGN levels and different variables (CARS, SRS). However, the results showed no significant correlation between SCGN and these scales. (CARS, r=-0.03, p=0.86; SRS, r=0.21, p=0.20). Conclusion: The low SCGN plasma levels in children with ASD probably indicate that SCGN might be implicated in the pathogenesis of autism. However, these data should be treated with caution until further investigations are performed using larger sample sizes to determine whether the decrease in plasma SCGN levels is a mere consequence of autism or it plays a pathogenic role in the disease.
Publication Details
Page(s) 222-226
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 4, Year: 2017

Request the full text from PASTIC

References
2000.Diagnostic and statistical manual of mental disorders (4th edn, Text Revision), -
GibneySM,DrexhagHA, 2013.Evidence for a dysregulated immune system in the etiology of psychiatric disorders,J Neuroimmune Pharmacol 8 900 -20
WalshP,ElsabbaghM,BoltonP,Singh , I., 2011.In search of biomarkers for autism: Scientific, social and ethical challenges,Nat Rev Neurosci 12 603 -12
LothE,SpoorenW,HamLM,IsaacMB,Auriche-BenichouC,BanaschewskiT, 2015.Identification and validation of biomarkers for autism spectrum disorders,Nat Rev Drug Discov 15 70 -3
WagnerL,OliyarnykO,GartnerW,NowotnyP,GroegerM,KasererK, 2000.Cloning and expression of secretagogin, a novel neuroendocrine- and pancreatic islet of Langerhansspecific Ca2+-binding protein,J Biol Chem 275 24740 -51
MajM,MilenkovicI,BauerJ,BerggårdT,VeitM,Ilhan-MutluA, 2012.Novel insights into the distribution and functional aspects of the calcium binding protein secretagogin from studies on rat brain and primary neuronal cell culture,Front Mol Neurosci 5 84 -
BittoCA,BingmanL,BittovaRO,FrederickBG,FoxGN,PhillipsJr, 2009.X-ray structure of Danio rerio secretagogin: A hexaEF-hand calcium sensor,Proteins 76 477 -83
RomanovRA,AlparA,ZhangMD,ZeiselA,CalasA,LandryM, 2014.A secretagogin locus of the mammalian hypothalamus controls stress hormone release,EMBO J -
MulderJ,SpenceL,TortorielloG,DinieriJ A,UhlenM,ShuiB, 2010.Secretagogin is a Ca2+-binding protein identifying prospective extended amygdala neurons in the developing mammalian telencephalon,Eur J Neurosci 31 2166 -77
LiuQ,LaiM. Location, 2016.and functions of secretagogin protein,Zhejiang Da Xue Xue Bao Yi Xue Ban 45 56 -60
BlandiniF,BraunewellKH,Manahan-VaughanD,OrziF, 2004.Neurodegeneration and energy metabolism: From chemistry to clinics,Cell Death Differ 11 479 -84
GreeneJR,RadenahmadN,WilcockGK,NealJW,PearsonRC, 2001.Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease,Neuropathol Appl Neurobiol 27 339 -42
RogstamA,LinseS,LindqvistA,JamesP,WagnerL,BerggardT., 2007.Binding of calcium ions and SNAP-25 to the hexa-EF-hand protein secretagogin,Biochem J 401 353 -63
2007.Calcium signaling,Cell 131 1047 -58
NiggliE,ShirokovaN., 2007.A guide to sparkology: The taxonomy of elementary cellular Ca2+ signaling events,Cell Calcium 42 379 -87
HermesM,EichhoffG,GaraschukO, 2010.Intracellular calcium signalling in Alzheimer's disease,J Cell Mol Med 14 30 -41
CamandolaS,MattsonMP, 1813.Aberrant sub cellular neuronal calcium regulation in aging and Alzheimer's disease,Biochim. Biophys Acta 965 -73
BashirS,ZeinaR,MuhammadD,Al-Ayadhi L, 2014.Role of hedgehog protein family members in autistic children,Neurol Psychiatry Brain Res 20 63 -7
ConstantinoJN,DavisSA,ToddRD, 2003.Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interviewrevised,J Autism Dev Disord 33 427 -33
WangJ,LeeLC,ChenYS,HsuJW, 2012.Assessing autistic traits in a Taiwan preschool population: Cross-cultural validation of the social responsiveness scale (SRS),J Autism Dev Disord 42 2450 -9
Di MartinoA,ShehzadZ,KellyC,RoyAK,GeeDG,UddinLQ, 2009.Relationship between cingulo-insular functional connectivity and autistic traits in neurotypical adults,Am J Psychiatry 166 891 -9
QasemH,Al-AyadhiL,El-AnsaryA, 2016.Cysteinyl leukotriene correlated with 8-isoprostane levels as predictive biomarkers for sensory dysfunction in autism,Lipids Health Dis 15 130 -
AlpárA,AttemsJ,MulderJ,HökfeltT,HarkanyT., 2012.The renaissance of Ca2+ binding proteins in the nervous system: secretagogin takes center stage,Cell Signal 24 378 -87
PellicanoE., 2010.The development of core cognitive skills in autism: A 3-year prospective study,Child Dev 81 1400 -16
YuiK,TanumaN,YamadaH,KawasakiY., 2016.Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder,Int J Devl Neuroscience -
0

Citations

0

Downloads

56

Views